Shao Q. Yao
4 Science Drive 2
Singapore, 117543, Singapore
Singapore, 117543, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Dual-Site Covalent Targeting Enables BD2-Selective BET Inhibition With Potent Antitumor Activity in Mice.
Journal: Angewandte Chemie (International ed. in English)
Published: April 04, 2026
Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.
Journal: Angewandte Chemie (International ed. in English)
Published: March 15, 2026
Reversible one-step acylation facilitates mitochondrial delivery of functional RNA.
Journal: Chemical science
Published: February 21, 2026
Large-Scale Profiling of Kinase Degradation by Using Norbornene-Based Hydrophobic Tag (HyT) Strategy.
Journal: Angewandte Chemie (International ed. in English)
Published: December 18, 2025
SPECTRAL: An Intelligent and Ultra-Sensitive Photonic Hydrogel Platform for Biomarker-Based Cancer Prediction.
Journal: Angewandte Chemie (International ed. in English)
Published: December 14, 2025
Lipid Droplet-Targeted Biomimetic Liposomes Potentiate Chemo-Ferroptosis Therapy in Leukemia.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 13, 2025
Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy.
Journal: Biomaterials research
Published: July 17, 2025
Multifunctional nanoagonist enhances photodynamic therapy-driven in situ cancer vaccination by inhibiting tumor thrombosis.
Journal: Journal of nanobiotechnology
Published: June 18, 2025
Cell-Active, Irreversible Covalent Inhibitors Targeting a Surface-Exposed Non-Catalytic Lysine on Aurora a Kinase by Using Squarate Chemistry.
Journal: Angewandte Chemie (International ed. in English)
Published: May 16, 2025
Lysine-Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals.
Journal: Angewandte Chemie (International ed. in English)
Published: December 18, 2024
Cell-Active, Arginine-Targeting Irreversible Covalent Inhibitors for Non-Kinases and Kinases.
Journal: Angewandte Chemie (International ed. in English)
Published: November 17, 2024
Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies.
Journal: Journal of advanced research
Published: June 28, 2024
Last Updated: 09/26/2026